• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓形成后综合征的预防与治疗:VAS - 欧洲血管病学/血管医学独立基金会立场文件

The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.

作者信息

Cosmi Benilde, Stanek Agata, Kozak Matja, Wennberg Paul W, Kolluri Raghu, Righini Marc, Poredos Pavel, Lichtenberg Michael, Catalano Mariella, De Marchi Sergio, Farkas Katalin, Gresele Paolo, Klein-Wegel Peter, Lessiani Gianfranco, Marschang Peter, Pecsvarady Zsolt, Prior Manlio, Puskas Attila, Szuba Andrzej

机构信息

Division of Angiology and Blood Coagulation, Department of Specialty, Diagnostic and Experimental Medicine, S. Orsola Malpighi University Hospital Research Institute IRCSS, University of Bologna, Bologna, Italy.

Inter-University Research Center on Vascular Diseases & Angiology Unit, University of Milan, L Sacco Hospital, VAS-European Independent Foundation in Angiology/Vascular Medicine, Milan, Italy.

出版信息

Front Cardiovasc Med. 2022 Feb 24;9:762443. doi: 10.3389/fcvm.2022.762443. eCollection 2022.

DOI:10.3389/fcvm.2022.762443
PMID:35282358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8907532/
Abstract

IMPORTANCE

The post-thrombotic syndrome (PTS) is the most common long-term complication of deep vein thrombosis (DVT), occurring in up to 40-50% of cases. There are limited evidence-based approaches for PTS clinical management.

OBJECTIVE

To provide an expert consensus for PTS diagnosis, prevention, and treatment.

EVIDENCE-REVIEW: MEDLINE, Cochrane Database review, and GOOGLE SCHOLAR were searched with the terms "post-thrombotic syndrome" and "post-phlebitic syndrome" used in titles and abstracts up to September 2020.

FILTERS WERE

English, Controlled Clinical Trial / Systematic Review / Meta-Analysis / Guideline. The relevant literature regarding PTS diagnosis, prevention and treatment was reviewed and summarized by the evidence synthesis team. On the basis of this review, a panel of 15 practicing angiology/vascular medicine specialists assessed the appropriateness of several items regarding PTS management on a Likert-9 point scale, according to the RAND/UCLA method, with a two-round modified Delphi method.

FINDINGS

The panelists rated the following as appropriate for diagnosis: 1-the Villalta scale; 2- pre-existing venous insufficiency evaluation; 3-assessment 3-6 months after diagnosis of iliofemoral or femoro-popliteal DVT, and afterwards periodically, according to a personalized schedule depending on the presence or absence of clinically relevant PTS. The items rated as appropriate for symptom relief and prevention were: 1- graduated compression stockings (GCS) or elastic bandages for symptomatic relief in acute DVT, either iliofemoral, popliteal or calf; 2-thigh-length GCS (30-40 mmHg at the ankle) after ilio-femoral DVT; 3- knee-length GCS (30-40 mmHg at the ankle) after popliteal DVT; 4-GCS for different length of times according to the severity of periodically assessed PTS; 5-catheter-directed thrombolysis, with or without mechanical thrombectomy, in patients with iliofemoral obstruction, severe symptoms, and low risk of bleeding. The items rated as appropriate for treatment were: 1- thigh-length GCS (30-40 mmHg at the ankle) after iliofemoral DVT; 2-compression therapy for ulcer treatment; 3- exercise training. The role of endovascular treatment (angioplasty and/or stenting) was rated as uncertain, but it could be considered for severe PTS only in case of stenosis or occlusion above the inguinal ligament, followed by oral anticoagulation.

CONCLUSIONS AND RELEVANCE

This position paper can help practicing clinicians in PTS management.

摘要

重要性

血栓形成后综合征(PTS)是深静脉血栓形成(DVT)最常见的长期并发症,发生率高达40%-50%。PTS临床管理的循证方法有限。

目的

为PTS的诊断、预防和治疗提供专家共识。

证据综述

检索了MEDLINE、Cochrane数据库综述和谷歌学术,检索词为截至2020年9月标题和摘要中使用的“血栓形成后综合征”和“血栓性静脉炎后综合征”。

筛选条件为

英文、对照临床试验/系统评价/荟萃分析/指南。证据综合团队对有关PTS诊断、预防和治疗的相关文献进行了综述和总结。在此综述的基础上,一个由15名血管病/血管医学执业专家组成的小组根据RAND/UCLA方法,采用两轮改良德尔菲法,以9分李克特量表评估了若干PTS管理项目的适宜性。

研究结果

专家小组成员将以下项目评定为适宜诊断项目:1-Villalta量表;2-既往静脉功能不全评估;3-在诊断髂股或股腘静脉DVT后3-6个月进行评估,之后根据是否存在临床相关PTS的个性化时间表定期评估。评定为适宜缓解症状和预防的项目有:1-分级压力弹力袜(GCS)或弹力绷带用于缓解急性DVT(髂股、腘或小腿)的症状;2-髂股静脉DVT后使用大腿长度的GCS(脚踝处压力为30-40 mmHg);3-腘静脉DVT后使用膝盖长度的GCS(脚踝处压力为30-40 mmHg);4-根据定期评估的PTS严重程度使用不同时长的GCS;5-对髂股静脉阻塞、症状严重且出血风险低的患者进行导管定向溶栓,可联合或不联合机械性血栓清除术。评定为适宜治疗的项目有:1-髂股静脉DVT后使用大腿长度的GCS(脚踝处压力为30-40 mmHg);2-用于溃疡治疗的加压治疗;3-运动训练。血管内治疗(血管成形术和/或支架置入术)作用的评定为不确定,但仅在腹股沟韧带上方存在狭窄或闭塞且伴有口服抗凝治疗的严重PTS病例中可考虑使用。

结论及意义

本立场文件有助于临床执业医师进行PTS管理。

相似文献

1
The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.血栓形成后综合征的预防与治疗:VAS - 欧洲血管病学/血管医学独立基金会立场文件
Front Cardiovasc Med. 2022 Feb 24;9:762443. doi: 10.3389/fcvm.2022.762443. eCollection 2022.
2
Compression therapy for prevention of post-thrombotic syndrome.用于预防血栓形成后综合征的压迫疗法。
Cochrane Database Syst Rev. 2017 Sep 26;9(9):CD004174. doi: 10.1002/14651858.CD004174.pub3.
3
Posterior tibial vein approach to catheter-directed thrombolysis for iliofemoral deep venous thrombosis.经胫后静脉入路导管直接溶栓治疗髂股型深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):629-634. doi: 10.1016/j.jvsv.2019.01.064. Epub 2019 Jun 21.
4
Clinical Assessment of Endovascular Stenting Compared with Compression Therapy Alone in Post-thrombotic Patients with Iliofemoral Obstruction.腔内支架置入与单纯压迫治疗在髂股静脉阻塞性血栓后综合征患者中的临床评估。
Eur J Vasc Endovasc Surg. 2015 Jul;50(1):101-7. doi: 10.1016/j.ejvs.2015.03.029. Epub 2015 Apr 25.
5
Surgical and non-surgical approaches in the management of lower limb post-thrombotic syndrome.下肢血栓后综合征的手术和非手术治疗方法。
Expert Rev Cardiovasc Ther. 2021 Mar;19(3):191-200. doi: 10.1080/14779072.2021.1876563. Epub 2021 Jan 26.
6
Compression therapy for treating post-thrombotic syndrome.用于治疗血栓后综合征的压迫疗法。
Cochrane Database Syst Rev. 2019 Sep 18;9(9):CD004177. doi: 10.1002/14651858.CD004177.pub2.
7
Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.导管定向溶栓治疗深静脉血栓形成:文献综述与实践考量
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S228-S237. doi: 10.21037/cdt.2017.09.15.
8
Midterm outcome of pharmacomechanical catheter-directed thrombolysis combined with stenting for treatment of iliac vein compression syndrome with acute iliofemoral deep venous thrombosis.药物机械导管溶栓联合支架置入治疗髂静脉压迫综合征合并急性髂股深静脉血栓形成的中期结果。
J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):24-30. doi: 10.1016/j.jvsv.2019.03.020. Epub 2019 Jul 18.
9
The post-thrombotic syndrome: a 2012 therapeutic update.血栓形成后综合征:2012年治疗进展
Curr Treat Options Cardiovasc Med. 2013 Apr;15(2):153-63. doi: 10.1007/s11936-012-0224-3.
10
Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.经导管溶栓治疗急性髂股静脉血栓形成后髂静脉支架置入术失败的结果和预测因素。
J Vasc Surg Venous Lymphat Disord. 2019 Mar;7(2):153-161. doi: 10.1016/j.jvsv.2018.08.014. Epub 2019 Jan 16.

引用本文的文献

1
Acute iliofemoral deep venous thrombosis in adolescents and young adults is associated with hypercoagulable states and a significant incidence of post-thrombotic syndrome.青少年和青年急性髂股深静脉血栓形成与高凝状态及血栓形成后综合征的高发生率相关。
J Vasc Surg Venous Lymphat Disord. 2025 Feb 11;13(4):102211. doi: 10.1016/j.jvsv.2025.102211.
2
Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial.阿司匹林联合利伐沙班与单用利伐沙班预防血栓形成后综合征患者静脉支架内血栓形成的多中心、多国、随机、开放标签ARIVA试验
Circulation. 2025 Mar 25;151(12):835-846. doi: 10.1161/CIRCULATIONAHA.124.073050. Epub 2025 Jan 28.
3
Prognosis and Factors 4 to 10 Years After Deep Vein Thrombosis: A Long-Term Follow-up Cohort Study.深静脉血栓形成后 4 至 10 年的预后和影响因素:一项长期随访队列研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241266820. doi: 10.1177/10760296241266820.
4
Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis.住院患者全身免疫炎症指数与下肢深静脉血栓形成风险的相关性:一项10年回顾性分析
Front Cardiovasc Med. 2023 Jun 16;10:1211294. doi: 10.3389/fcvm.2023.1211294. eCollection 2023.
5
Deep vein thrombosis causing abdominal wall varicosities.深静脉血栓形成导致腹壁静脉曲张。
J Surg Case Rep. 2023 Feb 8;2023(2):rjad004. doi: 10.1093/jscr/rjad004. eCollection 2023 Feb.
6
More is less: Effect of ICF-based early progressive mobilization on severe aneurysmal subarachnoid hemorrhage in the NICU.少即是多:基于国际功能、残疾和健康分类的早期渐进性活动对新生儿重症监护病房严重动脉瘤性蛛网膜下腔出血的影响
Front Neurol. 2022 Dec 14;13:951071. doi: 10.3389/fneur.2022.951071. eCollection 2022.
7
Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus.抗栓装置疗法可提高急性心肌梗死合并II型糖尿病患者在重症监护病房的生存率。
Front Cardiovasc Med. 2022 Jul 19;9:948924. doi: 10.3389/fcvm.2022.948924. eCollection 2022.

本文引用的文献

1
Biases of Villalta scale in classifying post-thrombotic syndrome in patients with pre-existing chronic venous disease.Villalta 量表在分类伴有既往慢性静脉疾病的血栓后综合征患者中的偏倚。
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1025-1030. doi: 10.1016/j.jvsv.2020.01.018. Epub 2020 Mar 21.
2
External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.SOX-PTS 评分在近端深静脉血栓形成患者前瞻性多中心试验中的外部验证。
J Thromb Haemost. 2020 Jun;18(6):1381-1389. doi: 10.1111/jth.14791. Epub 2020 Apr 9.
3
The 2020 update of the CEAP classification system and reporting standards.CEAP 分类系统和报告标准 2020 年更新版。
J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342-352. doi: 10.1016/j.jvsv.2019.12.075. Epub 2020 Feb 27.
4
The direct oral anticoagulants may also be effective against the risk of post-thrombotic syndrome.直接口服抗凝剂可能对预防血栓形成后综合征也有效。
Intern Emerg Med. 2020 Apr;15(3):365-367. doi: 10.1007/s11739-019-02251-9. Epub 2019 Dec 23.
5
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.超声加速导管直接溶栓与抗凝预防血栓形成后综合征(CAVA):一项单盲、多中心、随机试验
Lancet Haematol. 2020 Jan;7(1):e40-e49. doi: 10.1016/S2352-3026(19)30209-1. Epub 2019 Nov 27.
6
Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion.Villalta 量表是否能捕捉到血栓后综合征的本质?一项基于患者体验和专家意见的定性研究。
J Thromb Haemost. 2019 Oct;17(10):1707-1714. doi: 10.1111/jth.14557. Epub 2019 Jul 23.
7
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.药物机械性导管定向溶栓治疗深静脉血栓形成
N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.
8
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.利伐沙班或依诺肝素/维生素 K 拮抗剂治疗急性深静脉血栓形成患者的血栓后综合征。一项事后分析。
Thromb Haemost. 2016 Sep 27;116(4):733-8. doi: 10.1160/TH16-01-0041. Epub 2016 Sep 1.
9
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.抗栓治疗 VTE 疾病:CHEST 指南和专家小组报告。
Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.
10
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.导管定向溶栓治疗深静脉血栓形成后血栓形成后综合征(CaVenT):一项开放标签随机对照试验的5年随访结果
Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6.